T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG) (original) (raw)
Frequency of proteinase 3 (PR3)-specific autoreactive T cells determined by cytokine flow cytometry in Wegener's granulomatosis
Antje Mueller
Journal of Autoimmunity, 2004
View PDFchevron_right
Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)
Cornelis Melief
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis
Felipe Andrade
Arthritis and Rheumatism, 2010
View PDFchevron_right
Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis
Cees Kallenberg
Rheumatology, 1998
View PDFchevron_right
T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis
Megan Griffith
Clinical and Experimental Immunology, 1996
View PDFchevron_right
Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides
Jan Willem Cohen Tervaert
Kidney International, 2001
View PDFchevron_right
Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis
Dirk Roos
Clinical & Experimental Immunology, 2002
View PDFchevron_right
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA
Anca Anca
Rheumatology, 2001
View PDFchevron_right
Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-α 1 -antitrypsin complexation to disease activity in Wegener's granulomatosis
Cees Kallenberg
Clinical & Experimental Immunology, 1993
View PDFchevron_right
In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase
Cees Kallenberg
Arthritis & Rheumatism, 2002
View PDFchevron_right
Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
Fionnuala Hickey
Scientific Reports, 2015
View PDFchevron_right
ANCA patients have T cells responsive to complementary PR-3 antigen
Gloria Preston
Kidney International, 2008
View PDFchevron_right
Impairment and Differential Expression of PR3 and MPO on Peripheral Myelomonocytic Cells with Endothelial Properties in Granulomatosis with Polyangiitis
Johannes Wessels
International Journal of Nephrology, 2012
View PDFchevron_right
Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission
Wayel Abdulahad
Arthritis & Rheumatism, 2007
View PDFchevron_right
Patients with Wegener’s granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells
Naeem Khan
Immunology, 2010
View PDFchevron_right
The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs
Judy savige
Journal of Clinical Pathology, 2004
View PDFchevron_right
Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)
Philippe Grange
Arthritis & Rheumatism, 2011
View PDFchevron_right
Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders
Cees Kallenberg
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis
Hermann Haller
American Journal of Kidney Diseases, 1996
View PDFchevron_right
Proteinase 3 associated with Wegener's granulomatosis
Wolfgang Goldmann
Cell Biology International, 2021
View PDFchevron_right
ANCA: Serology in Wegener′s granulomatosis
Vandana Pradhan
Indian Journal of Medical Sciences, 2005
View PDFchevron_right
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis
Amiram Ariel
Journal of Clinical Investigation, 2015
View PDFchevron_right
Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3
Ariel Teitel
Journal of Immunology, 1992
View PDFchevron_right
Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis
Cees Kallenberg
Annals of the New York Academy of Sciences, 2005
View PDFchevron_right
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study
Cees Kallenberg
Arthritis & Rheumatism, 2000
View PDFchevron_right
Clinical Outcomes of Patients with Dual Positivity for Proteinase 3 and Myeloperoxidase Specific Antineutrophil Cytoplasmic Antibodies
Paul Gatenby
Journal of Clinical & Cellular Immunology, 2015
View PDFchevron_right
Neutrophil Membrane Expression of Proteinase 3 (PR3) Is Related to Relapse in PR3-ANCA-Associated Vasculitis
Cees Kallenberg
Journal of the American Society of Nephrology, 2002
View PDFchevron_right
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA): Minor target antigens in ANCA-associated vasculitis
Jobert Barin
Clinical and Experimental Immunology, 2007
View PDFchevron_right
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission
Sophie Ohlsson
Clinical and Experimental Immunology, 2003
View PDFchevron_right
Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies
Giorgio Fassina
Journal of Leukocyte Biology, 2004
View PDFchevron_right
Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3
Mohamed Daha
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)
Noel Rose
Clinical & Experimental Immunology, 2007
View PDFchevron_right